Biological: cizutamig

DRUG2 trials

Sponsors

Peking University First Hospital, Ruijin Hospital

Conditions

Immunoglobulin A Nephropathy (IgAN)Systemic Sclerosis (SSc)

Early Phase 1

A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy

Enrolling by invitationNCT07135219

Peking University First HospitalImmunoglobulin A Nephropathy (IgAN)

Start: 2025-07-16End: 2027-01-31Target: 15Updated: 2025-08-22

A Study of Cizutamig in Systemic Sclerosis

Not yet recruitingNCT07158996

Ruijin HospitalSystemic Sclerosis (SSc)

Start: 2025-09-04End: 2027-08-31Target: 10Updated: 2025-09-08